Trending Now
IGM Biosciences Inc. (NASDAQ: IGM) Reports Progress in Development of its...
IGM Biosciences Inc. (NASDAQ: IGM) has announced progress in two Phase I clinical studies evaluating an anti-SARS-CoV-2 IgM monoclonal antibody, IGM-6268, for prevention and...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Rolls Out TAVLESSE In Europe
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced the commercial availability of chronic immune thrombocytopenia (ITP) treatment TAVLESSE (fostamatinib disodium) in Europe.
The announcement which came on Thursday...
MAKE IT MODERN
LATEST REVIEWS
NFT Stocks Back on the Radar After Quarter Billion Dollar Fund...
The NFT space is one of the most interesting and controversial market ideas to emerge over the past decade. The concept amounts...
MAKE IT MODERN
PERFORMANCE TRAINING
Live Sports Stocks are Back! (MSGS, CHDN, BTDG, WWE)
The NFL is back! Sort of. But it’s a great sign for the live sports space, overall. And that’s a space that has been...
MediciNova, Inc. (NASDAQ:MNOV) Agree With Japan’s Mie University and Biocomo to Develop a Vaccine...
The pharmaceutical industry is convinced that there is still room to combat the rapid spread of coronavirus. It has emphasized the need for companies...
CytoDyn (OTCMKTS:CYDY) Investor Update Unveils Coming Uplisting and Potential Interim Readout Followed by a...
Yesterday CytoDyn Inc. (OTCMKTS) delivered a gripping investor update after hours clearly projecting a bright path forward that...
Exelis Inc. (NASDAQ:EXEL) And Iconic Therapeutics Release Promising Data On ICON-2 In Treatment Of...
Exelis Inc. (NASDAQ:EXEL) and Iconic Therapeutics have announced new preclinical data supporting the continued development of ICON-2 in the treatment of different solid tumors....
Affimed Inc. (NASDAQ:AFMD) Publishes Phase 1b Study Results Evaluating AFM13 Combination With KEYTRUDA In...
Affimed Inc. (NASDAQ:AFMD) has announced the publication of the Phase 1b combination study of AFM13, its CD30/CD16A innate cell engager (ICE®) with...
MAKE IT MODERN
